• Jennifer Richmond, MbahOlive MOMUniversity of North Carolina at Chapel Hill Gillings School of Global Public Health, Department of Health Policy and Management, 135 Dauer Drive, 1101 McGavran-Greenberg Hall, CB 741, Chapel Hill, NC, 27599-7411, USA., DardSofia ZSZUniversity of North Carolina at Chapel Hill, North Carolina Translational and Clinical Sciences Institute, Brinkhous-Bullitt Building, 2nd Floor CB 7064, 160 N. Medical Drive, Chapel Hill, NC 27599-7064, USA., Lauren C Jordan, Katherine S Cools, Cleo A Samuel, KhanJalaal MJMCone Health Cancer Center, Radiation Oncology, 2400 W. Friendly Avenue, Greensboro, NC 27403, USA., and ManningMatthew AMACone Health Cancer Center, Radiation Oncology, 2400 W. Friendly Avenue, Greensboro, NC 27403, USA..
• University of North Carolina at Chapel Hill Gillings School of Global Public Health, Department of Health Behavior, 135 Dauer Drive, 302 Rosenau Hall, CB #7440, Chapel Hill, NC 27599-7440, USA; American Institutes for Research, Research and Evaluation, Domestic, 100 Europa Drive, Suite 315, Chapel Hill, NC 27517, USA. Electronic address: Jennifer_Richmond@unc.edu.
• J Natl Med Assoc. 2020 Apr 1; 112 (2): 209-214.

BackgroundLung cancer is the leading cause of cancer death in the US, and significant racial disparities exist in lung cancer outcomes. For example, Black men experience higher lung cancer incidence and mortality rates than their White counterparts. New screening recommendations for low-dose computed tomography (LDCT) promote earlier detection of lung cancer in at-risk populations and can potentially help mitigate racial disparities in lung cancer mortality if administered equitably. Yet, little is known about the extent of racial differences in uptake of LDCT.ObjectiveTo evaluate potential racial disparities in LDCT screening in a large community-based cancer center in central North Carolina.MethodsWe conducted a retrospective study of the initial patients undergoing LDCT in a community-based cancer center (n = 262). We used the Pearson chi-squared test to assess potential racial disparities in LDCT screening.ResultsStudy results suggest that Black patients may be less likely than White patients to receive LDCT screening when eligible (χ2 = 51.41, p < 0.0001).ConclusionCollaboration among healthcare providers, researchers, and decision makers is needed to promote LDCT equity.Copyright © 2020 National Medical Association. Published by Elsevier Inc. All rights reserved.

35 keywords...

hide…